platinum (cisplatin or carboplatin)

DRUG3 trials

Sponsors

Qilu Hospital of Shandong University, Jiangsu Hansoh Pharmaceutical Co., Ltd., Newsoara HYK Biopharmaceutical (Shanghai) Co., Ltd.

Conditions

Advanced Solid TumorsColorectal CancerNon-Small Cell Lung CancerNon-Small-Cell Lung CancerSCLC, Extensive Stage

Phase 1

A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors

Not yet recruitingNCT06963502

Jiangsu Hansoh Pharmaceutical Co., Ltd.Advanced Solid Tumors, Colorectal Cancer, Non-Small Cell Lung Cancer

Start: 2025-05-30End: 2030-04-30Target: 762Updated: 2025-05-09

Olvi-Vec Combined With Platinum Plus Etoposide Therapy in Patients With Late Phase SCLC

RecruitingNCT07136285

Newsoara HYK Biopharmaceutical (Shanghai) Co., Ltd.SCLC, Extensive Stage

Start: 2023-07-24End: 2026-12-31Target: 27Updated: 2025-12-03

Phase 4

Intercalated Combination of Chemotherapy and Tyrosine Kinase Inhibitors as First-line Treatment for Patients With Non-Small-Cell Lung Cancer

Qilu Hospital of Shandong UniversityNon-Small-Cell Lung Cancer

Start: 2014-01-31End: 2017-12-31Target: 250Updated: 2016-03-29